BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

4:50 PM
 | 
Mar 10, 2010
 |  BC Extra  |  Politics & Policy

FDA studying biosimilars pathway

FDA is investigating whether it has legal authority to create a pathway for approval of biosimilars, Principal Deputy Commissioner Joshua Sharfstein told the House Energy and Commerce Committee's health subcommittee on Wednesday. Responding to a question from Rep. Michael...

Read the full 174 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >